DTC
EDIT icon

Deep Track Capital’s Editas Medicine EDIT Stock Holding History

Deep Track Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,900,334
Closed -$16.7M – 70
2024
Q3 		$16.7M Sell
4,900,334
-1,099,666
-18% -$4.79M 0.53% 49
2024
Q2 		$28M Buy
6,000,000
+472,710
+9% +$2.67M 0.84% 36
2024
Q1 		$41M Buy
5,527,290
+54,204
+1% +$450K 1.17% 33
2023
Q4 		$55.4M Sell
5,473,086
-1,628,849
-23% -$14.3M 1.85% 21
2023
Q3 		$55.4M Buy
7,101,935
+3,648,191
+106% +$31.3M 2.14% 16
2023
Q2 		$28.4M Buy
+3,453,744
New +$30.1M 1.32% 24

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deep Track Capital's EDIT Position: Q4 2024 in Review

Deep Track Capital sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 4,900,334 shares — an estimated $16.7M sold.

Deep Track Capital first reported a position in EDIT in Q2 2023 and held it in 6 quarters. The position peaked at $55.4M in Q4 2023. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Deep Track Capital reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Deep Track Capital sold 4,900,334 Editas Medicine shares in Q4 2024, an estimated $16.7M.
  • Deep Track Capital first reported a position in Editas Medicine in Q2 2023 and held it in 6 quarters.
  • Deep Track Capital's Editas Medicine position peaked at $55.4M in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Deep Track Capital's 13F filing for Q4 2024, filed 14 Feb 2025.